Dave Rosa

Dave Rosa is executive vice president/chief strategy and growth officer at Intuitive. Since joining Intuitive in 1996, Rosa has held leadership positions in commercial, engineering, clinical development, marketing and product development. From 2019 to 2021, he was executive vice president/chief business officer, and from 2015 to 2019, he served as executive vice president/chief commercial officer. Rosa has been a passionate supporter and evangelist of da Vinci technology since its inception.

Prior to Intuitive, Rosa contributed to the development of trans-esophageal transducers for Acuson Corporation. He serves on the board of directors’ compensation committee for Kardium, a private company based in Vancouver, British Columbia, Canada, that focuses on the treatment of atrial fibrillation, and for Arterys, a private company based in San Francisco that focuses on using artificial intelligence to improve the evaluation of radiologic images. Rosa also serves as chairman of the board of the joint venture between Intuitive Surgical and Fosun Pharma, based in Shanghai, China.

A holder of multiple patents, Rosa earned a Bachelor of Science in mechanical engineering from California Polytechnic University at San Luis Obispo, and a Master of Science in mechanical engineering from Stanford University.